Not available
Quote | Akcea Therapeutics Inc. (NASDAQ:AKCA)
Last: | $18.17 |
---|---|
Change Percent: | 0.17% |
Open: | $18.15 |
Close: | $18.17 |
High: | $18.17 |
Low: | $18.13 |
Volume: | 813,044 |
Last Trade Date Time: | 10/09/2020 04:44:24 am |
News | Akcea Therapeutics Inc. (NASDAQ:AKCA)
Pfizer (PFE) has initiated a Phase 2b study of vupanorsen (AKCEA-ANGPTL3-L) in statin-treated patients with elevated non-high-density lipoprotein cholesterol (non-HDL-C) and triglycerides (TGs), says Ionis Pharmaceuticals (IONS) and its subsidiary Akcea Therapeutics (AKCA).The study, Targetin...
Ionis and Akcea win prestigious Prix Galien Award for TEGSEDI® (inotersen) as Best Biotechnology Product PR Newswire BOSTON and CARLSBAD, Calif., Oct. 30, 2020 BOSTON and CARLSBAD, Calif. , Oct. 30, 2020 /PRNewswire/ -- Ionis Pharmaceuticals, In...
Message Board Posts | Akcea Therapeutics Inc. (NASDAQ:AKCA)
Subject | By | Source | When |
---|---|---|---|
znewcar1: AKCA 60% v6,7M c18.28 f101M H19.65 gap tap HOD dip and sideways | znewcar1 | investorshangout | 08/31/2020 8:31:23 PM |
Any thoughts on why so low today? | Sidney | investorshub | 03/29/2018 6:44:14 PM |
So Volatile. Any thoughts on why the | Thoro | investorshub | 08/31/2017 6:10:31 PM |
Like how clean the board is .Some heavy | Rodney213 | investorshub | 08/09/2017 1:58:13 AM |
Dropped heavy yesterday but bounced back some today. | dinosaurbob | investorshub | 08/04/2017 9:27:40 PM |
News, Short Squeeze, Breakout and More Instantly...
Akcea Therapeutics Inc. Company Name:
AKCA Stock Symbol:
NASDAQ Market:
Akcea Therapeutics Inc. Website:
Ionis and Akcea win prestigious Prix Galien Award for TEGSEDI® (inotersen) as Best Biotechnology Product PR Newswire BOSTON and CARLSBAD, Calif., Oct. 30, 2020 BOSTON and CARLSBAD, Calif. , Oct. 30, 2020 /PRNewswire/ -- Ionis Pharmaceuticals, In...
Ionis Pharmaceuticals completes acquisition of Akcea Therapeutics Transaction creates a stronger, more efficient company PR Newswire CARLSBAD, Calif., Oct. 12, 2020 CARLSBAD, Calif. , Oct. 12, 2020 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (NASDAQ: IONS...
NEW YORK, NY / ACCESSWIRE / September 23, 2020 / Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a national securities firm headquartered at the Empire State Building in New York City, is investigating: Akcea Therapeutics, Inc. (NASDAQ: AKCA ), relating...